The University of Alabama at Birmingham has been awarded a $7 million research grant to continue its leadership in pioneering clinical trials in the treatment of neurofibromatosis 1 and 2 and schwannomatosis, all rare genetic diseases. According to the Birmingham Business Journal, the circumstances of these diseases lead to non-cancerous tumors forming on the nerves and potentially causing blindness, hearing loss, learning disabilities, pain or deformity.
Read More
0 Comments Click here to read/write comments
Tags: 2012, Alabama, University of Alabama, University of Alabama Birmingham, BioResearch Product Faire Event, UAB, Birmingham, AL, research grant